Lv3
270 积分 2023-10-21 加入
Using serum cTnT/CK combined with anti-Ro52 antibodies to screen for myocardial involvement and assess prognosis in idiopathic inflammatory myopathy
5小时前
已完结
Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure
26天前
已完结
Multicenter study to improve clinical interpretation of anticardiolipin and anti–beta2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome
1个月前
已完结
Dilemmas in the diagnosis and management of antiphospholipid syndrome
1个月前
已完结
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions
1个月前
已完结
Is β2-glycoprotein I prothrombotic?
1个月前
已关闭
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: Guidance from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (ISTH-SSC) Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
1个月前
已完结
Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities
1个月前
已完结
Application of ACR/EULAR Classification Criteria in real life: thrombotic patients positive for Lupus Anticoagulant only
1个月前
已关闭
Are the 2023 ACR/EULAR classification criteria a step forward in the management of antiphospholipid syndrome? A literature-based and clinical practice appraisal
1个月前
已关闭
皖公网安备34019202002308
